Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC

被引:29
|
作者
Oba, A. [1 ,2 ]
Bao, Q. R. [1 ,3 ]
Barnett, C. C. [1 ,4 ]
AI-Musawi, M. H. [1 ]
Croce, C. [1 ]
Schulick, R. D. [1 ,5 ]
Del Chiaro, M. [1 ,5 ]
机构
[1] Univ Colorado, Dept Surg, Div Surg Oncol, Anschutz Med Campus, Denver, CO 80202 USA
[2] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Hepatobiliary & Pancreat Surg, Tokyo, Japan
[3] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
[4] Rocky Mt Reg Vet Affairs Med Ctr, Dept Surg, Aurora, CO USA
[5] Univ Colorado, Ctr Canc, Denver, CO 80262 USA
关键词
Pancreatic ductal adenocarcinoma; neoadjuvant therapy; neoadjuvant chemotherapy; neoadjuvant chemoradiotherapy; pancreatectomy; borderline resectable; locally advanced; FOLFIRINOX; gemcitabine; nab-paclitaxel; PORTAL-VEIN RESECTION; CELIAC AXIS RESECTION; SUPERIOR MESENTERIC VEIN; MODIFIED APPLEBY PROCEDURE; DISTAL PANCREATECTOMY; NEOADJUVANT THERAPY; VENOUS INVOLVEMENT; ARTERIAL RESECTION; PERIOPERATIVE OUTCOMES; PROGNOSTIC-FACTORS;
D O I
10.1177/1457496919900413
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background and Aims: It has become clear that vein resection and reconstruction for pancreatic ductal adenocarcinoma (PDAC) is the standard of care as supported by multiple guidelines. However, resection of large peri-pancreatic arteries remains debatable. Materials and Methods: This review examines the current state of vascular resection with curative intent for PDAC in the last 5 years. Herein, we consider venous (superior mesenteric vein, portal vein), as well as arterial (superior mesenteric artery, celiac trunk, hepatic artery) resection or both with or without reconstruction. Results: Improvement of multidrug chemotherapy has revolutionized care for PDAC that should shift traditional surgical thinking from an anatomical classification of resectability to a prognostic and biological classification. Conclusion: The present review gives an overview on the results of pancreatectomy associated with vascular resection, with consideration of new perspectives offered by the availability of better systemic therapies.
引用
收藏
页码:18 / 28
页数:11
相关论文
共 50 条
  • [41] Prognostic Metabolic Signatures in Pancreatic Ductal Adenocarcinoma (PDAC).
    Karasinska, Joanna
    Kalloger, Steve
    Wong, Hui-Li
    Renouf, Daniel
    Schaeffer, David
    [J]. MODERN PATHOLOGY, 2018, 31 : 680 - 680
  • [42] Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC).
    Krantz, Benjamin A.
    Tsui, Dana
    Lowery, Maeve Aine
    Capanu, Marinela
    Yu, Kenneth H.
    Kelsen, David Paul
    Gedvilaite, Erika
    Zhang, Liguo
    Selcuklu, S. Duygu
    You, Daoqi
    Pernicka, Jennifer S. Golia
    Do, Richard K. G.
    Iacobuzio-Donahue, Christine A.
    O'Reilly, Eileen Mary
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [43] pH Regulatory Transporters in Pancreatic Ductal Adenocarcinoma (PDAC)
    Kong, Su Chii
    Christensen, Sandra
    Hoffmann, Else Kay
    Novak, Ivana
    Pedersen, Stine Falsig
    [J]. FASEB JOURNAL, 2013, 27
  • [44] Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study
    Lovecek, Martin
    Skalicky, Pavel
    Klos, Dusan
    Bebarova, Linda
    Neoral, Cestmir
    Ehrmann, Jiri, Jr.
    Zapletalova, Jana
    Svebisova, Hana
    Vrba, Radek
    Stasek, Martin
    Yogeswara, Tharani
    Havlik, Roman
    [J]. BIOMEDICAL PAPERS-OLOMOUC, 2016, 160 (02): : 280 - 286
  • [45] The impact of cancer stem cell markers in the tissues of pancreatic ductal adenocarcinoma for prognosis after surgical resections
    Inokawa, Yoshikuni
    Yamada, Suguru
    Hayashi, Masamichi
    Sunagawa, Yuki
    Sonohara, Fuminori
    Takami, Hideki
    Hattori, Norifumi
    Kanda, Mitsuro
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Koike, Masahiko
    Kodera, Yasuhiro
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [46] Pancreatic resections after chemo radiotherapy for locally advanced ductal adenocarcinoma: Analysis of perioperative outcome and survival
    Massucco, Paolo
    Capussotti, Lorenzo
    Magnino, Antonella
    Sperti, Elisa
    Gatti, Marco
    Muratore, Andrea
    Sgotto, Enrico
    Gabriele, Pietro
    Aglietta, Massimo
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (09) : 1201 - 1208
  • [47] Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)
    Martinez-Muniz, Andres E.
    Sivanand, Sharanya
    Vander Heiden, Matthew
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [48] Do Transanastomotic Pancreatic Ductal Stents After Pancreatic Resections Improve Outcomes?
    Shukla, Parul J.
    Barreto, Savio G.
    Fingerhut, Abe
    [J]. PANCREAS, 2010, 39 (05) : 561 - 566
  • [49] Complex Vascular Resections for Retroperitoneal Soft Tissue Sarcoma
    Devaud, Nicolas A.
    Butte, Jean M.
    de la Maza, Juan C.
    Hugo, Sebastian von Muhlenbrock
    Cardona, Kenneth
    [J]. CURRENT ONCOLOGY, 2023, 30 (03) : 3500 - 3515
  • [50] A contemporary view on vascular resections and reconstruction during hepatectomies
    Tirloni, Luca
    Bartolini, Ilenia
    Gazia, Carlo
    Scarinci, Andrea
    Grazi, Gian Luca
    [J]. UPDATES IN SURGERY, 2024,